NHP · National Healthcare Properties, Inc.
Price & Indicators
The closing range uses available history since Apr 22, 2026; less than a full year is stored.
Up next
Metrics snapshot
Useful current figures from the complete screener profile.
Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average monthly revenue per occupied room | $6,391 | Three months ended June 30, 2026 filing | — |
| Average occupancy | 84.1% | Three months ended June 30, 2026 filing | — |
| NAREIT FFO attributable to common stockholders non-GAAP | $11.95M | Three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP Net loss attributable to common stockholders -$8.14M
+$16.4M Depreciation and amortization related to real estate assets
+$3.78M Impairment charges
+$0K Loss (gain) on sale of real estate investments
-$89K Depreciation on real estate assets related to non-controlling interests
= NAREIT FFO attributable to common stockholders $11.95M
|
|||
| NOI non-GAAP | $31.15M | Three months ended June 30, 2025 filing | — |
| Normalized NFFO attributable to common stockholders non-GAAP | $10.87M | Three months ended June 30, 2026 filing | — |
GAAP → non-GAAP reconciliationGAAP NAREIT FFO attributable to common stockholders $11.95M
+$130K Acquisition and transaction related
-$1.24M Derivatives mark-to-market and terminations
+$7K Casualty-related charges, net
+$0K Gain on extinguishment of debt
-$7K Normalizing items related to non-controlling interests
+$21K Other normalizing items
= Normalized NFFO attributable to common stockholders $10.87M
|
|||
| Occupancy at June 30 | 93.1% | the three months ended June 30, 2026 filing | — |
| Total communities | 39 | the three months ended June 30, 2026 filing | — |
| OMF Same Store Cash NOI growth non-GAAP | -0.4% | Q2 2026 | — |
| OMF Same Store ending occupancy non-GAAP | 94.3% | Q2 2026 | — |
| SHOP Same Store average occupancy non-GAAP | 84.1% | Q2 2026 | — |
| SHOP Same Store Cash NOI growth non-GAAP | 20.1% | Q2 2026 | — |
| SHOP Same Store Cash NOI Margin non-GAAP | 22.4% | Q2 2026 | — |
| SHOP Same Store RevPOR non-GAAP | 5.9% | Q2 2026 | — |
| Total Facility non-GAAP | $1.2B | As of August 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NHP
this stock
National Healthcare Properties, Inc.
|
$1.11B | — | -3.3% | — | 5.3% |
|
WELL
Welltower Inc.
|
$157.45B | +20.2% | +35.6% | 111.0 | 2.5% |
|
VTR
Ventas, Inc.
|
$41.94B | +5.7% | +18.5% | 151.4 | 3.9% |
|
OHI
Omega Healthcare Investors Inc
|
$13.37B | -0.5% | +13.2% | 15.7 | 4.8% |
|
DOC
Healthpeak Properties, Inc.
|
$12.77B | +15.2% | +4.5% | 52.9 | 3.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NHP | -5.8% | -5.3% | — | -5.3% | — |
| SPY | +1.3% | +2.1% | +9.0% | +1.5% | +13.5% |
| vs SPY | -7.1% | -7.4% | — | -6.8% | — |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.